Why the study?
Can plasma biomarkers predict early post-discharge death or heart failure readmission in patients hospitalized for acute heart failure?
Can plasma biomarkers predict early post-discharge death or heart failure readmission in patients hospitalized for acute heart failure?
Plasma biomarkers may be useful for risk stratification of early post-discharge events in patients hospitalized for acute heart failure.
May support biomarker-based post-discharge risk stratification in acute HF; leaves open prospective validation before guiding care.
Different biomarkers predicted low risk vs. high risk of early post-discharge death or heart failure readmission in patients hospitalized for acute heart failure.
No takes yet. Share an insight, caveat, or question.
Demissei et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: